ICD-10 Coding for Essential Thrombocythemia(D47.3)
Complete ICD-10-CM coding and documentation guide for Essential Thrombocythemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Essential Thrombocythemia
D47-D47.9Primary Range
Neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
This range includes essential thrombocythemia, a myeloproliferative disorder characterized by excessive platelet production.
Other and unspecified diseases of blood and blood-forming organs
Includes secondary thrombocytosis, which must be differentiated from essential thrombocythemia.
Key Information: ICD-10 code for essential thrombocythemia
Essential facts and insights about Essential Thrombocythemia
Primary ICD-10-CM Code for essential thrombocythemia
Decision Criteria
clinical Criteria
- Presence of JAK2, CALR, or MPL mutation
documentation Criteria
- Bone marrow biopsy confirming megakaryocyte hyperplasia
Applicable To
- Primary thrombocythemia
- Essential thrombocytosis
Clinical Validation Requirements
- Platelet count ≥450 x10³/L
- JAK2, CALR, or MPL mutation
- Bone marrow biopsy showing megakaryocyte hyperplasia
Code-Specific Risks
- Incorrectly coding secondary thrombocytosis as D47.3
- Missing documentation of genetic mutation
Coding Notes
- Ensure documentation specifies 'essential' or 'primary' thrombocythemia.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Hemorrhagic disorder due to extrinsic circulating anticoagulants
D68.32Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Essential Thrombocythemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D47.3.
Impact
Clinical: May lead to misdiagnosis., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation Strategy
Ensure all genetic test results are documented in the patient's chart.
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation Strategy
Verify documentation for genetic testing and bone marrow biopsy results.
Impact
Lack of documentation for genetic testing can lead to audit issues.
Mitigation Strategy
Ensure all genetic test results are included in the patient's medical record.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Essential Thrombocythemia, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Essential Thrombocythemia
Use these documentation templates to ensure complete and accurate documentation for Essential Thrombocythemia. These templates include all required elements for proper coding and billing.
Diagnosis of essential thrombocythemia
Specialty: HematologyRequired Elements
- Platelet count
- Genetic mutation status
- Bone marrow biopsy results
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Essential Thrombocythemia? Ask your questions below.